Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Balancing lipid synthesis and oxidation promotes B cell response to vaccination during immunosuppression
Elizabeth A. Thompson, Alexis Figueroa, Katerina Roznik, Nicole E. Skinner, Santosh Dhakal, Shuai Li, Luca Biavati, Laura A. Sena, Laila Stoddart, Karli Redinger, Samuel B. Warner, Sabra L. Klein, Nadine Rouphael, Joel N. Blankson, Yolanda Eby, Robert D. Leone, Peter S. Heeger, Mark A. Robien, Christian P. Larsen, Erika L. Pearce, Edward J. Pearce, Hongkai Ji, Andrew H. Karaba, Dorry L. Segev, Aaron A.R. Tobian, William A. Werbel, Andrea L. Cox, Justin R. Bailey
Elizabeth A. Thompson, Alexis Figueroa, Katerina Roznik, Nicole E. Skinner, Santosh Dhakal, Shuai Li, Luca Biavati, Laura A. Sena, Laila Stoddart, Karli Redinger, Samuel B. Warner, Sabra L. Klein, Nadine Rouphael, Joel N. Blankson, Yolanda Eby, Robert D. Leone, Peter S. Heeger, Mark A. Robien, Christian P. Larsen, Erika L. Pearce, Edward J. Pearce, Hongkai Ji, Andrew H. Karaba, Dorry L. Segev, Aaron A.R. Tobian, William A. Werbel, Andrea L. Cox, Justin R. Bailey
View: Text | PDF
Research Article Immunology Metabolism

Balancing lipid synthesis and oxidation promotes B cell response to vaccination during immunosuppression

  • Text
  • PDF
Abstract

Pharmacologic immunosuppression is essential for preventing organ rejection and controlling autoimmunity but profoundly impairs humoral immunity, increasing the risk of vaccine failure and infection. The mechanisms by which immunosuppressive therapies disrupt human B cell responses remain poorly defined. Here, we identified dysregulated lipid metabolism as a central determinant of impaired vaccine response in solid organ transplant recipients (SOTRs). Using high-dimensional immune profiling, single-cell transcriptomics, and functional metabolic assays, we found that effective B cell responses required a homeostatic balance between lipid synthesis and fatty acid oxidation (FAO). The widely used immunosuppressive agent mycophenolic acid (MPA) was strongly associated with vaccine nonresponses and induced excessive lipid synthesis, lipid accumulation, and mitochondrial stress in B cells. In contrast, CD11c+ B cells retained the capacity to differentiate into plasmablasts in the presence of MPA through elevated expression of CPT1a, a mitochondrial FA transporter, and enhanced FAO. These cells were found to be a key feature of early effective vaccine responses in healthy individuals and SOTRs. Notably, pharmacologic inhibition of cholesterol synthesis partially restored plasmablast differentiation in the presence of MPA. These findings identify B cell lipid metabolism as a critical and targetable regulator of human humoral immunity during immunosuppression.

Authors

Elizabeth A. Thompson, Alexis Figueroa, Katerina Roznik, Nicole E. Skinner, Santosh Dhakal, Shuai Li, Luca Biavati, Laura A. Sena, Laila Stoddart, Karli Redinger, Samuel B. Warner, Sabra L. Klein, Nadine Rouphael, Joel N. Blankson, Yolanda Eby, Robert D. Leone, Peter S. Heeger, Mark A. Robien, Christian P. Larsen, Erika L. Pearce, Edward J. Pearce, Hongkai Ji, Andrew H. Karaba, Dorry L. Segev, Aaron A.R. Tobian, William A. Werbel, Andrea L. Cox, Justin R. Bailey

×

Figure 2

MMF and MPA directly modulate immune cell lipid metabolism.

Options: View larger image (or click on image) Download as PowerPoint
MMF and MPA directly modulate immune cell lipid metabolism.
(A–D) Seahor...
(A–D) Seahorse OCR following a mitochondrial stress test. (A) OCR of ex vivo PBMCs from SOTRs receiving no MMF, high-dose MMF, or low-dose MMF and HCs (n = 3 per group and average of 4 replicates per condition). (B) OCR of healthy PBMCs treated in vitro with high-dose (5 μM) or low-dose (0.05 μM) MPA for 24 hours followed by culturing in limited nutrient media for 24 hours prior to a mitochondrial stress test (n = 3 per group and average of 4 wells per condition). (C and D) Healthy PBMCs were prepared for mitochondrial stress test as described in A and exposed to etomoxir (2 μM) 30 minutes prior to the assay. (E) Healthy PBMCs were prepared for the mitochondrial stress test as described in A and exposed to BSA-palmitate (16.5 μM) or BSA 30 minutes prior to assay. (F) Summary of induction of the OCR at baseline following supplementation with palmitate (16.5 μM), octanoic acid (200 μM), glucose/pyruvate (10 mM/1 mM), or glutamine (2 mM) 30 minutes prior to plating. Data are normalized to media only controls from untreated to high-dose MPA–treated wells (n = 6 per group and average of 4 wells per condition). (G) Healthy PBMCs were treated in vitro with high-dose (5 μM) or low-dose (0.05 μM) MPA for 24 hours and stained with Oil Red O to measure lipid droplet accumulation. Scale bars: 20 μm. (H) The proportion of cells occupied by Oil Red O staining was quantified using CellProfiler; each dot represents 1 field of vision. (I) Proposed effects of MPA on lipid metabolism. Data are presented as the mean ± SEM. Significance tested using 2way ANOVA (F) or Kruskal-Wallis (E). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts